Plasma fractionation is a process of separating various components of plasma. It is used in in prevention and treatment of life threatening diseases caused by trauma, immunologic disorders, and infections. Plasma fractionation process is used in treating protein deficiency in healthcare applications. It is also used in production of packaging material for industrial applications. The removal or inactivation of viruses and prions is a prime function of plasma fractionation.
Increasing use of immunoglobulin in therapeutic areas and prevalence of emphysema & AATD are factors fueling the growth of the world plasma fractionation market. However, high cost, limited reimbursement, and stringent government regulations obstruct growth of the market. On the other hand, increasing number of hemophilic patients are creating opportunities for growth.
The world plasma fractionation market is segmented based on product, application, end user, and geography. On the basis of products, the market is classified into albumin, immunoglobulins, coagulation factor concentrates, and others. The immunoglobulin segment is further classified into subcutaneous immunoglobulin (SCIg), intravenous immunoglobulin (IVIg), and others. Coagulation factor concentrates are divided into factor VIII, factor IX, factor XIII, Von Willebrand factor, prothrombin coagulation concentrates, and fibrinogen concentrates. Applications included in the report are neurology, hematology, immunology, critical care, and others. End users covered in the report are hospitals and clinical research laboratories. Geographically, the market is divided into North America, Europe, Asia-Pacific, and Latin America, Middle East and Africa (LAMEA).
The prominent companies operating in the market are Grifols SA, Baxter International Inc., CSL Ltd., Bio Product Laboratory, Octapharma AG, Sanquin, Laboratoire Franais du Fractionnement et des Biotechnologies, Kedrion, and Biotest. Partnerships, collaborations, mergers & acquisitions, agreements, expansions, joint ventures, and others are some of the key strategies adopted by these prominent manufacturers to strengthen their position in the market.
KEY BENEFITS FOR STAKEHOLDERS:
KEY MARKET SEGMENTS:
Key Market Players:
SIMILAR MARKET STUDIES
Blood Market by Product [Whole Blood Collection (System and Reagents), Source Plasma Collections (System and Reagents) Blood Therapeutics (IVIG, Albumin, Hyperimmune, Factor VIII, Factor IX, and Others), Blood Typing Products (System and Reagents), Blood Screening (Systems and Reagents), Blood Processing Equipment & Associated Products (System and Reagents)] and End User (Blood & Blood Component Bank, Diagnostic Laboratories, Ambulatory Surgical Centers, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2017-2023
Blood is a major necessity for patients suffering from injuries and viral infections, which require blood transfusion. The patients are either given whole blood or blood components for quick recovery and healing, resulting into increased demand for blood banks.
July 2017 | $5370 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research